Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Nonacog alfa |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
nonacog alpha |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing only nonacog alfa (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
nonacog alpha |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Nonacog alfa only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
nonacog alpha |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Nonacog alfa-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
nonacog alpha |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing nonacog alfa in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
nonacog alpha |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely nonacog alfa 250 international unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) |
Has precise active ingredient |
False |
nonacog alpha |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely nonacog alfa 250 international unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
False |
nonacog alpha |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely nonacog alfa 1000 international unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) |
Has precise active ingredient |
False |
nonacog alpha |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely nonacog alfa 1000 international unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
False |
nonacog alpha |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely nonacog alfa 500 international unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) |
Has precise active ingredient |
False |
nonacog alpha |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely nonacog alfa 500 international unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
False |
nonacog alpha |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely nonacog alfa 500 unit/1 vial powder for conventional release solution for injection (clinical drug) |
Has precise active ingredient |
True |
nonacog alpha |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely nonacog alfa 500 unit/1 vial powder for conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
nonacog alpha |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely nonacog alfa 250 unit/1 vial powder for conventional release solution for injection (clinical drug) |
Has precise active ingredient |
True |
nonacog alpha |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely nonacog alfa 250 unit/1 vial powder for conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
nonacog alpha |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely nonacog alfa 1000 unit/1 vial powder for conventional release solution for injection (clinical drug) |
Has precise active ingredient |
True |
nonacog alpha |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely nonacog alfa 1000 unit/1 vial powder for conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
nonacog alpha |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |